Graham Neil 4
4 · Evelo Biosciences, Inc. · Filed Apr 10, 2020
Insider Transaction Report
Form 4
Graham Neil
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-04-08+150,000→ 150,000 totalExercise: $3.72Exp: 2030-04-08→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]These options will vest as to 25% of the total grant on April 6, 2021 with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to continued employment on such dates.